Related Experiment Video

Updated: Jul 3, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Pathobiology and Interactions of the MiTF Signaling Pathways

Maria S Tretiakova1

  • 1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.

Advances in Anatomic Pathology
|July 2, 2026
PubMed

Insights

The MiT/TFE family of transcription factors (MiTF, TFE3, TFEB, TFEC) are crucial in cancer development and cellular regulation. Understanding their roles may lead to new cancer diagnostics and treatments.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The MiT/TFE family of transcription factors (MiTF, TFE3, TFEB, TFEC) are key regulators of cellular processes.
  • These factors control autophagy, lysosome biogenesis, and energy metabolism.
  • Dysregulation of MiT/TFE genes is implicated in various cancers.

Purpose of the Study:

  • To elucidate the roles of MiT/TFE transcription factors in cellular homeostasis and cancer.
  • To explore their involvement in oncogenic and stress-adaptive pathways.
  • To identify potential diagnostic and therapeutic strategies targeting MiT/TFE factors.

Main Methods:

  • Analysis of MiT/TFE gene family functions.
  • Investigation of transcriptional regulation in cancer.
  • Exploration of cellular homeostasis and stress response pathways.

Main Results:

  • MiT/TFE factors regulate critical cellular pathways including autophagy and lysosome biogenesis.
  • Chromosomal alterations involving MiT/TFE genes are linked to renal cell carcinoma, melanoma, and sarcomas.
  • These factors play a role in energy metabolism within cancer cells.

Conclusions:

  • MiT/TFE transcription factors are vital in cancer pathophysiology and cellular adaptation.
  • Further understanding of MiT/TFE pathways can inform cancer diagnostics and treatment.
  • Targeting MiT/TFE regulation offers potential for novel cancer therapies.
Keywords:
MITFTFE3TFEBTFECmicrophtalmia transcription factorssignaling pathways

More Related Videos

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima09:13

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima

Published on: August 12, 2018

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...